Effects of cardiovascular angiotensin II type 1 receptor blockade on nitric oxide synthase inhibition in patients with insulin resistance syndrome

Author： Brillante Divina Gracilla   O'Sullivan Anthony John   Brillante Ruby Esmeralda   Howes Laurence Guy  

Publisher： Informa Healthcare

ISSN： 0803-7051

Source： Blood Pressure, Vol.18, Iss.3, 2009-06, pp. : 142-148

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of Selective Angiotensin II Type 1 Receptor Blockade with Losartan on Arterial Compliance in Patients with Mild Essential Hypertension

By KLEMSDAL TOR O.   MOAN ANDREAS   KJELDSEN SVERRE E.  

Blood Pressure, Vol. 8, Iss. 4, 1999-12 ,pp. : 214-219

Informa Healthcare

Access to resources Recommend Favorite

The increased angiotensin II (type 1) receptor density in myocardium of type 2 diabetic patients is prevented by blockade of the renin–angiotensin system

By Reuter H.   Adam C.   Grönke S.   Zobel C.   Frank K.   Müller-Ehmsen J.   Brabender J.   Schwinger R.  

Diabetologia, Vol. 49, Iss. 12, 2006-12 ,pp. : 3067-3074

Springer Publishing Company

Access to resources Recommend Favorite

Angiotensin II Type 1 Receptor Blockade: a Novel Therapeutic Concept

By JOHNSTON COLIN I.  

Blood Pressure, Vol. 9, Iss. 1, 2000-05 ,pp. : 9-13

Informa Healthcare

Access to resources Recommend Favorite

Is Combined Angiotensin-converting Enzyme Inhibition and Angiotensin Receptor Blockade Associated with Increased Risk of Cardiovascular Death in Hemodialysis Patients?

By  

Current Hypertension Reviews, Vol. 8, Iss. 4, 2012-11 ,pp. : 256-266

Bentham Science Publishers

Access to resources Recommend Favorite

Dual Effects of Angiotensin II Type 2 Receptor on Cardiovascular Hypertrophy

By Inagami T.   Senbonmatsu T.  

Trends in Cardiovascular Medicine, Vol. 11, Iss. 8, 2001-11 ,pp. : 324-328

Elsevier

Access to resources Recommend Favorite